Tag: car_t_cell_therapy
-
Immune Activation Key to CAR T Therapy Success in Glioblastoma, Penn Medicine Finds
Penn Medicine research reveals glioblastoma patients on dual-target CAR T cell therapy live longer with activated natural killer cells, while non-responders show more immunosuppressive cells, paving the way for therapy improvements.
HealthBusinessPolitics and GovernmentLaw EnforcementMedical ScienceReal EstateGeneral PoliticsEnvironmentSocial Issues GlioblastomaCAR T cell therapyPenn MedicineNatural Killer CellsImmunosuppressionCancer ResearchImmunotherapy
-
Wharton Student Awarded Medal of Honor Amidst Penn's Breakthroughs in Cancer Treatment and AI Innovation
A Wharton MBA student receives the Medal of Honor. Penn researchers achieve cancer treatment breakthroughs with CAR T cell therapy and fungi, while advancing AI in medical imaging and public policy leadership.
HealthScience & TechnologyPolitics and GovernmentMediaMedical ScienceArtificial IntelligenceEducationGeneral PoliticsSocial IssuesMiddle East Nicholas DockeryMedal of HonorCAR T cell therapyCancer ResearchUniversity of PennsylvaniaPublic Policy
-
Groundbreaking CAR T Cell Therapy Offers Potential Cures for B-Cell Lymphoma
New long-term data from Penn Medicine shows CAR T cell therapy leads to 10-year remissions and potential cures for over one-third of B-cell lymphoma patients, marking a significant advance in cancer treatment.
HealthMediaWorldSocial IssuesMedical ScienceEducationDigital and Print PublishingEnvironmentMiddle East CAR T cell therapyB-cell lymphomaCancer TreatmentRemissionPenn MedicineStephen J. SchusterFDA
-
Pioneering CAR T Cell Therapy Opens Doors for Kidney Transplant Patients
Penn Medicine's clinical trial uses CAR T cell therapy to enable kidney transplants for two end-stage patients, offering transformative hope for those on waiting lists.
HealthBusinessScience & TechnologyWeatherMedical ScienceArtificial IntelligenceEconomyReal EstateClimate ChangeEducation Penn MedicineCAR T cell therapyKidney transplantClinical trialAli NajiEnd-stage kidney diseaseMedical breakthrough